Co-Authors
This is a "connection" page, showing publications co-authored by Elisabeth Puchhammer-Stöckl and Alexander Zoufaly.
Connection Strength
1.534
-
Human recombinant soluble ACE2 in severe COVID-19. Lancet Respir Med. 2020 11; 8(11):1154-1158.
Score: 0.904
-
Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19. Genet Med. 2021 05; 23(5):963-967.
Score: 0.232
-
Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays. J Clin Microbiol. 2021 04 20; 59(5).
Score: 0.059
-
SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses. Sci Immunol. 2021 03 04; 6(57).
Score: 0.058
-
Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2. Sci Transl Med. 2020 12 09; 12(573).
Score: 0.057
-
Dynamics of CD4 T Cell and Antibody Responses in COVID-19 Patients With Different Disease Severity. Front Med (Lausanne). 2020; 7:592629.
Score: 0.057
-
Diagnosis of COVID-19 using multiple antibody assays in two cases with negative PCR results from nasopharyngeal swabs. Infection. 2021 Feb; 49(1):171-175.
Score: 0.056
-
Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in Different Stages of Infection: Comparison of Commercial Enzyme-Linked Immunosorbent Assays and Rapid Tests. J Infect Dis. 2020 07 06; 222(3):362-366.
Score: 0.056
-
Successful management of the first reported case in Austria of COVID-19 with ARDS. Infection. 2020 Aug; 48(4):647-651.
Score: 0.055